Security Snapshot

AgomAb Therapeutics NV - Common Shares, no nominal value per share Institutional Ownership

CUSIP: JYH220000

13F Institutional Holders and Ownership History

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
48,855,821

Key facts

  • JYH220000 - AgomAb Therapeutics NV - Common Shares, no nominal value per share is tracked under CUSIP JYH220000.
  • Latest finished 13F holder period is not available.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Quarterly ownership records are not available yet for this CUSIP.
  • This page updates as SEC-backed holdings history becomes available.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

JYH220000

Latest holder period

n/a

13F holders

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
JYH220000
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 10% 4,873,680 FMR LLC 27 Feb 2026
Pontifax Management 4 G.P. (2015) Ltd. 6.8% 3,305,846 Pontifax VI G.P. L.P. 31 Mar 2026
Redmile Group, LLC 5.6% 2,735,926 Redmile Group, LLC 31 Mar 2026
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .